Germany · Delayed Price · Currency is EUR DSM-Firmenich AG Company Description
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health.
The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins.
The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets.
This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition.
The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services.
The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
| Country | Switzerland |
| Founded | 1902 |
| Industry | Chemicals and Allied Products |
| Employees | 26,301 |
| CEO | Dimitri de Vreeze |
Contact Details
Address: Wurmisweg 576 Kaiseraugst, 4303 Switzerland | |
| Phone | 41 61 815 17 26 |
| Website | dsm-firmenich.com |
Stock Details
| Ticker Symbol | ZX6 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Dimitri de Vreeze | Chief Executive Officer |
| Ralf Schmeitz | Chief Financial Officer |
| Emmanuel Butstraen | Chief Operating Officer |
| Dave Huizing | Head of Investor Relations |